Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pronzato

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Journal of Chemotherapy (Florence, Italy)|August 1, 1993
Lymphoblastoid interferon in advanced breast cancer: a phase II studyC Naso, C Simoni, L Merlini, et al.
Seminars in Oncology|April 1, 1991
Lonidamine in metastatic breast cancerR Rosso, D Amoroso, G Gardin, et al.
Anticancer Research|March 28, 2001
Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancerA Vigani, F Pensa, F Vaira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinomaS Toma, R Palumbo, M Vincenti, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Phase II trials of idarubicin, a new anthracyclineR Rosso, A Ardizzoni, P Conte, et al.
Chemotherapy|January 1, 1991
Continuous venous infusion of vinblastine in metastatic breast cancerP Pronzato, P Queirolo, M G Vidili, et al.
Critical Reviews in Oncology/Hematology|March 10, 2015
HER2-positive metastatic breast cancer: a changing scenarioG Mustacchi, L Biganzoli, P Pronzato, et al.
Archivio "E. Maragliano" Di Patologia E Clinica|January 1, 1979
[Critical evaluation of the use of the "Cosinor" method in the analysis of the circadian rhythm of blood cortisol in humans]L Papa, S Bertolini, R Balestreri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 8, 2008
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA studyM E Cazzaniga, P Pronzato, G Mustacchi, et al.
International Journal of Breast Cancer|February 15, 2012
Biological characteristics and medical treatment of breast cancer in young women-a featured population: results from the NORA studyP Pronzato, G Mustacchi, A De Matteis, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Journal of Chemotherapy (Florence, Italy)|August 1, 1993
Lymphoblastoid interferon in advanced breast cancer: a phase II studyC Naso, C Simoni, L Merlini, et al.
Seminars in Oncology|April 1, 1991
Lonidamine in metastatic breast cancerR Rosso, D Amoroso, G Gardin, et al.
Anticancer Research|March 28, 2001
Sequential high dose-density chemotherapy with two active regimens for advanced small cell lung cancerA Vigani, F Pensa, F Vaira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinomaS Toma, R Palumbo, M Vincenti, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Phase II trials of idarubicin, a new anthracyclineR Rosso, A Ardizzoni, P Conte, et al.
Chemotherapy|January 1, 1991
Continuous venous infusion of vinblastine in metastatic breast cancerP Pronzato, P Queirolo, M G Vidili, et al.
Critical Reviews in Oncology/Hematology|March 10, 2015
HER2-positive metastatic breast cancer: a changing scenarioG Mustacchi, L Biganzoli, P Pronzato, et al.
Archivio "E. Maragliano" Di Patologia E Clinica|January 1, 1979
[Critical evaluation of the use of the "Cosinor" method in the analysis of the circadian rhythm of blood cortisol in humans]L Papa, S Bertolini, R Balestreri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 8, 2008
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA studyM E Cazzaniga, P Pronzato, G Mustacchi, et al.
International Journal of Breast Cancer|February 15, 2012
Biological characteristics and medical treatment of breast cancer in young women-a featured population: results from the NORA studyP Pronzato, G Mustacchi, A De Matteis, et al.
Pageof 13